Can Bad Sleeping Habits Cause Migraines?
Title: Can Bad Sleeping Habits Cause Migraines?Category: Diseases and ConditionsCreated: 5/20/2022 12:00:00 AMLast Editorial Review: 5/20/2022 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - May 20, 2022 Category: Neurology Source Type: news

Yes, COVID vaccine boosters for children are safe
Earlier this week, the Food and Drug Administration authorized COVID-19 vaccine booster shots for children between the ages of 5 and 11 who received their second vaccine shot at least five months ago. So far, only the Pfizer –BioNTech booster has been authorized for those in this age group.“While it has largely been the case that COVID-19 tends to be less severe in children than adults,” said FDA commissioner Robert Califf in a statement, “the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer-term effect s, even following initially mild dis...
Source: UCLA Newsroom: Health Sciences - May 20, 2022 Category: Universities & Medical Training Source Type: news

What Is Monkeypox and Should You Be Worried?
A case of the rare and potentially dangerous monkeypox has been confirmed in the U.S., with two news cases appearing in the U.K., bringing the total number there to nine. The infected Massachusetts man had recently traveled to Canada and is now receiving treatment in hospital, according to the Centers for Disease Control and Prevention (CDC). The Department of Health said the case poses no risk to the public. It’s the first reported infection in the U.S. so far this year and follows reports of scattered cases in Europe. In addition, health officials in Canada are investigating up to 13 cases in Montreal, Radio-Canada...
Source: TIME: Health - May 19, 2022 Category: Consumer Health News Authors: Damian Shepherd and Alex Millson / Bloomberg Tags: Uncategorized bloomberg wire Disease healthscienceclimate Londontime Source Type: news

New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Causes Migraines in Females?
Title: What Causes Migraines in Females?Category: Diseases and ConditionsCreated: 7/2/2020 12:00:00 AMLast Editorial Review: 5/18/2022 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - May 18, 2022 Category: Neurology Source Type: news

What Does Migraine Do to the Brain?
Title: What Does Migraine Do to the Brain?Category: Diseases and ConditionsCreated: 5/18/2022 12:00:00 AMLast Editorial Review: 5/18/2022 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - May 18, 2022 Category: Neurology Source Type: news

Persistence of headache and its relation to other major sequelae following traumatic brain injury at 2-8  years after deployment-related traumatic brain injury in veterans of Afghanistan and Iraq wars - Couch JR, Stewart KE.
This study deals with headache in relation to other major sequelae of traumatic brain injury (TBI) in veterans of Iraq and Afghanistan wars over 8  years after experiencing a deployment-related TBI (DTBI). BACKGROUND: TBI occurred in 14%... (Source: SafetyLit)
Source: SafetyLit - May 16, 2022 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Revisiting the ICHD-3 criteria for headache attributed to mild traumatic injury to the head: insights from the Toronto Concussion Study Analysis of Acute Headaches Following Concussion - Langer LK, Bayley MT, Lawrence DW, Comper P, Kam A, Tam A, Saverino C, Wiseman-Hakes C, Ruttan L, Chandra T, Foster E, Gladstone J.
BACKGROUND: There is limited prospective data on the prevalence, timing of onset, and characteristics of acute headache following concussion/mild traumatic brain injury. METHODS: Adults diagnosed with concussion (arising from injuries not related t... (Source: SafetyLit)
Source: SafetyLit - May 16, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Stroke symptoms: Sudden headache may be a key sign of a brain aneurysm - are you at risk?
THE FEAR of haemorrhagic stroke looms large in the minds of many, but another silent killer which is less widely discussed is a brain aneurysm. Warning signs are rare with the condition. When a bulging artery ruptures, however, symptoms will be difficult to ignore. (Source: Daily Express - Health)
Source: Daily Express - Health - May 13, 2022 Category: Consumer Health News Source Type: news

Headache in Pregnancy: What's in the New ACOG Guidelines Headache in Pregnancy: What's in the New ACOG Guidelines
Despite a dearth of high-quality study data, experts offered recommendations for how best to manage women suffering headaches during and after childbirth.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 11, 2022 Category: Neurology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area (Source: ABC News: Health)
Source: ABC News: Health - May 10, 2022 Category: Consumer Health News Tags: Health Source Type: news

Pfizer to acquire Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults. (Source: World Pharma News)
Source: World Pharma News - May 10, 2022 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Web-Based Questionnaire Valid for Migraine, Tension-Type Headache
MONDAY, May 9, 2022 -- A seven-item web-based questionnaire is valid for diagnosing migraine, probable migraine (PM), and tension-type headache (TTH), according to a study published online April 29 in Scientific Reports. Kyung Min Kim, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2022 Category: Pharmaceuticals Source Type: news

Manual Therapy in the Treatment of Cervicogenic Headache Manual Therapy in the Treatment of Cervicogenic Headache
This study identified various manual therapy methods and techniques that are being evaluated for the treatment of cervicogenic headache. Which have shown the greatest efficacy?Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Johnson & Johnson Updates U.S. COVID-19 Vaccine Fact Sheet
NEW BRUNSWICK, NJ, May 5, 2022 - Our number one priority is the safety and well-being of those who use the Johnson & Johnson COVID-19 vaccine. Johnson & Johnson, in close coordination with the U.S. Food and Drug Administration (FDA), has updated its U.S. COVID-19 Vaccine Fact Sheet to increase awareness about the risk of thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially life-threatening condition. Language about the risk of TTS has been added to the first page of the Fact Sheet to increase its prominence. Following the update to the Fact Sheet, the Johnson & Johnson COVID-19 vaccine is now...
Source: Johnson and Johnson - May 5, 2022 Category: Pharmaceuticals Source Type: news